Synthesis, metabolism and cellular permeability of enzymatically stable dipeptide prodrugs of acyclovir

Anand, 2003, Novel dipeptide prodrugs of acyclovir for ocular herpes infections: bioreversion, antiviral activity and transport across rabbit cornea, Curr. Eye Res., 26, 151, 10.1076/ceyr.26.3.151.14893 Anand, 2003, Interactions of the dipeptide ester prodrugs of acyclovir with the intestinal oligopeptide transporter: competitive inhibition of glycylsarcosine transport in human intestinal cell line-Caco-2, J. Pharmacol. Exp. Ther., 304, 781, 10.1124/jpet.102.044313 Anand, 2004, Pharmacokinetics of novel dipeptide ester prodrugs of acyclovir after oral administration: intestinal absorption and liver metabolism, J. Pharmacol. Exp. Ther., 311, 659, 10.1124/jpet.104.069997 Atluri, 2004, Mechanism of a model dipeptide transport across blood-ocular barriers following systemic administration, Exp. Eye Res., 78, 815, 10.1016/j.exer.2003.10.020 Dawson, 1976, Herpes simplex eye infections: clinical manifestations, pathogenesis and management, Surv. Ophthalmol., 21, 121, 10.1016/0039-6257(76)90090-4 Dias, 2002, Ocular penetration of acyclovir and its peptide prodrugs valacyclovir and val-valacyclovir following systemic administration in rabbits: an evaluation using ocular microdialysis and LC–MS, Curr. Eye Res., 25, 243, 10.1076/ceyr.25.4.243.13488 Dressman, 1998, Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms, Pharm. Res., 15, 11, 10.1023/A:1011984216775 Fleming, 1997, Herpes simplex virus type 2 in the United States, 1976 to 1994, N. Engl. J. Med., 337, 1105, 10.1056/NEJM199710163371601 Friedrichsen, 2001, Application of enzymatically stable dipeptides for enhancement of intestinal permeability. Synthesis and in vitro evaluation of dipeptide-coupled compounds, Bioorg. Med. Chem., 9, 2625, 10.1016/S0968-0896(01)00066-9 Granero, 2006, Stability of valacyclovir: implications for its oral bioavailability, Int. J. Pharm., 317, 14, 10.1016/j.ijpharm.2006.01.050 Halioua, 1999, Epidemiology of genital herpes—recent advances, Eur. J. Dermatol., 9, 177 Ingels, 2004, Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers, Int. J. Pharm., 274, 221, 10.1016/j.ijpharm.2004.01.014 Jacobson, 1993, Valaciclovir (BW256U87): the l-valyl ester of acyclovir, J. Med. Virol., 150, 10.1002/jmv.1890410529 Katragadda, 2006, Simultaneous modulation of transport and metabolism of acyclovir prodrugs across rabbit cornea: an approach involving enzyme inhibitors, Int. J. Pharm., 320, 104, 10.1016/j.ijpharm.2006.04.010 McGill, 1976, Current and proposed management of ocular herpes simplex, Surv. Ophthalmol., 20, 358, 10.1016/S0039-6257(96)90004-1 Nashed, 2003, Synthesis and characterization of novel dipeptide ester prodrugs of acyclovir, Spectrochim. Acta, 59, 2033, 10.1016/S1386-1425(03)00007-6 Nielsen, 2001, Dipeptide model prodrugs for the intestinal oligopeptide transporter. Affinity for and transport via hPepT1 in the human intestinal Caco-2 cell line, J. Control. Release, 76, 129, 10.1016/S0168-3659(01)00427-8 Perry, 1996, Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections, Drugs, 52, 754, 10.2165/00003495-199652050-00009 Soul-Lawton, 1995, Absolute bioavailability and metabolic disposition of valaciclovir, the l-valyl ester of acyclovir, following oral administration to humans, Antimicrob. Agents Chemother., 39, 2759, 10.1128/AAC.39.12.2759 Steffansen, 1999, Stability, metabolism and transport of d-Asp(OBzl)-Ala—a model prodrug with affinity for the oligopeptide transporter, Eur. J. Pharm. Sci., 8, 67, 10.1016/S0928-0987(98)00062-1 Tamura, 1996, Metabolism, uptake, and transepithelial transport of the diastereomers of Val–Val in the human intestinal cell line, Caco-2, Pharm. Res., 13, 1213, 10.1023/A:1016068421243 Udata, 2003, Enhanced transport of a novel anti-HIV agent—cosalane and its congeners across human intestinal epithelial (Caco-2) cell monolayers, Int. J. Pharm., 250, 157, 10.1016/S0378-5173(02)00523-9